Fulltext

Use of complementary and alternative medicines in haemodialysis patients: a cross-sectional study from Palestine

Zyoud SH 1 , Al-Jabi SW 2 , Sweileh WM 3 , Tabeeb GH 4 , Ayaseh NA 4 , Sawafta MN 4 Show all authors , Khdeir RL 4 , Mezyed DO 4 , Daraghmeh DN 4 , Awang R 5

Affiliations 

  • 1 Poison Control and Drug Information Center (PCDIC), College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine. saedzyoud@yahoo.com
  • 2 Department of Clinical and Community Pharmacy, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine
  • 3 Department of Pharmacology and Toxicology, College of Medicine and Health Sciences, An-Najah National University, Nablus, 44839, Palestine
  • 4 PharmD program, College of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
  • 5 WHO Collaborating Centre for Drug Information, National Poison Centre, Universiti Sains Malaysia (USM), Penang, 11800, Malaysia
BMC Complement Altern Med, 2016 Jul 11;16:204.
PMID: 27400742 DOI: 10.1186/s12906-016-1196-8

Abstract

Complementary and alternative medicine (CAM), and herbal therapies, are accepted worldwide, and have been important from medical, sociological and economic perspectives, among haemodialysis (HD) patients. The primary aim of this study was to evaluate the use of CAM among patients with end-stage renal disease (ESRD) who are undergoing HD.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications